{"retracted":false,"update":{"timestamp":1475280000000,"doi":"10.1016/j.canlet.2016.07.026","type":"err"},"doi":"10.1016/j.canlet.2013.10.022","journal":"Cancer Letters","publisher":"Elsevier BV","title":"Corrigendum to ‘Ca2+/calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer’ [Cancer Lett. 344 (1), 119–128; March 1, 2014]"}
